V-Wave is developing a percutaneous implantable devices for treating patients with chronic Heart Failure (HF). The company’s proprietary unidirectional inter-atrial shunt is intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the patients’ overall quality of life.